Skip to main content


Fig. 2 | BMC Research Notes

Fig. 2

From: Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts

Fig. 2

a Representative western blots showing cellular levels of Src, pSrc, Akt, pAkt, and β-actin in RT112 and RT112rGEMCI20 cells after 24 h incubation with dasatinib. b Pixel density of western blots is given in percentage compared to untreated cell line (100 %). One of three independent experiments is shown here. *p ≤ 0.05 vs untreated cell line. c Wound healing migration assay. Effects of dasatinib (100 nM) treatment on RT112 or RT112rGEMCI20 cells were evaluated. Images of the closure of the scratch were captured at 0, 6, and 24 h. Representative images of scratch wound assays were shown (magnification ×100). d Quantification of wound repair was obtained from six measurements of every treatment from three independent experiments

Back to article page